Median Technologies, The Imaging Phenomics Company® (ALMDT:PA) is pleased to announce that James Golando, Chief of Operations at Median Technologies...
Read more
Sandoz, a Novartis division and the global leader in biosimilars, announces results from the EQUIRA study. The phase III comparative...
Read more
Adaptive Biotechnologies, a leader in combining next-generation sequencing (NGS) and sophisticated bioinformatics to profile T- and B-cell receptors of the...
Read more
Dermira, Inc and UCB announced the companies have agreed to end their development and commercialization agreement for CIMZIA (certolizumab pegol)...
Read more
Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced detailed results from the Phase 3 REPRISE trial of tolvaptan, which is under investigation...
Read more
PCI Pharma Services is excited to announce further market leading investment in fully contained Xcelodose® 600S technology at our center...
Read moreHalozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, today announced that Janssen Biotech, Inc. has initiated...
Read more
Daiichi Sankyo Company, Limited announced that the pivotal phase 3 placebo-controlled ENLIVEN (NCT02371369) study of pexidartinib met its primary endpoint...
Read more
Servier, Pfizer In and Cellectis announced that preliminary results from two phase 1 trials with UCART19, the allogeneic anti-CD19 CAR...
Read moreSancilio Pharmaceuticals Company, Inc. (SPCI) will present an update on the research program in the field of sickle cell disease,...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
